The nurse is preparing to administer digoxin (Lanoxin) to a client experiencing atrial fibrillation. Which of the following electrolyte imbalances would the nurse assess to reduce the incidence of toxicity with digoxin (Lanoxin)?
hypocalcemia
hypokalemia
hyperkalemia
hypernatremia
The Correct Answer is B
A. Hypocalcemia is not directly linked to digoxin toxicity; rather, it is more associated with calcium channel blockers.
B. Hypokalemia increases the risk of digoxin toxicity, as low potassium levels can enhance the effects of digoxin on the heart.
C. Hyperkalemia is not directly associated with toxicity; however, it can cause complications in patients taking digoxin.
D. Hypernatremia does not have a direct impact on digoxin toxicity; monitoring potassium levels is more critical.
Free Nursing Test Bank
- Free Pharmacology Quiz 1
- Free Medical-Surgical Quiz 2
- Free Fundamentals Quiz 3
- Free Maternal-Newborn Quiz 4
- Free Anatomy and Physiology Quiz 5
- Free Obstetrics and Pediatrics Quiz 6
- Free Fluid and Electrolytes Quiz 7
- Free Community Health Quiz 8
- Free Promoting Health across the Lifespan Quiz 9
- Free Multidimensional Care Quiz 10
View Related questions
Correct Answer is C
Explanation
A. Lung function tests are not relevant to atorvastatin therapy; they are more commonly associated with medications affecting the respiratory system.
B. Platelet counts are not routinely monitored for patients on atorvastatin unless there are specific concerns related to bleeding or clotting.
C. Liver function tests are critical for patients on atorvastatin because the medication can cause liver enzyme elevations, indicating potential hepatotoxicity. Routine monitoring ensures early detection of any liver complications.
D. Hemoglobin levels are not specifically related to atorvastatin use and are generally monitored in contexts involving anemia or bleeding.
Correct Answer is B
Explanation
A. Hypokalemia is not a common side effect of alteplase; instead, it may result from other factors.
B. Internal bleeding is a significant risk associated with thrombolytics like alteplase, as they promote the breakdown of clots but can also affect hemostasis.
C. Pancytopenia is not directly associated with alteplase use; it may occur with other medications or conditions.
D. Hypertension is not a common side effect of alteplase; instead, blood pressure may fluctuate but is not typically increased as a direct result of the medication.